Fluorescence photography in the evaluation of hyperpigmentation in photodamaged skin

J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):226-30. doi: 10.1016/s0190-9622(97)70285-8.

Abstract

Background: Treatment-related changes in hyperpigmentation are difficult to quantify with visible light photography, especially when the changes are subtle.

Objective: Our purpose was to determine the utility and reliability of fluorescence photography to measure changes in mottled and diffuse hyperpigmentation.

Methods: Thirty-two subjects, with mildly to moderately photodamaged skin, completed a 36-week, double-blind, vehicle-controlled study of tretinoin cream 0.025%. Clinical evaluation of hyperpigmentation as well as standard flash photographs and fluorescence photographs were obtained at baseline and week 36.

Results: The fluorescence photographs were evaluated blindly and yielded macule counts that decreased significantly from baseline in tretinoin-treated subjects compared with vehicle-treated subjects (31% vs 11% decrease; p = 0.02). Diffuse hyperpigmentation, as evaluated from the fluorescence photographs, decreased 16% from baseline for tretinoin-treated subjects and increased 5% for vehicle-treated subjects (p < 0.01). No significant differences in mottled or diffuse hyperpigmentation were observed between groups through clinical evaluation.

Conclusion: Fluorescence photography is a noninvasive method that is sensitive in the evaluation and quantification of distribution and changes of mottled and diffuse hyperpigmentation.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Double-Blind Method
  • Evaluation Studies as Topic
  • Fluorescence
  • Humans
  • Hyperpigmentation / drug therapy
  • Hyperpigmentation / etiology
  • Hyperpigmentation / pathology*
  • Keratolytic Agents / pharmacology
  • Keratolytic Agents / therapeutic use
  • Middle Aged
  • Photography / methods*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Skin Aging / drug effects
  • Skin Aging / pathology*
  • Tretinoin / pharmacology
  • Tretinoin / therapeutic use

Substances

  • Keratolytic Agents
  • Tretinoin